RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Suranganie Dharmawardhane to Paclitaxel

Back to Details
This is a "connection" page, showing publications Suranganie Dharmawardhane has written about Paclitaxel.
Suranganie Dharmawardhane
Connection Strength
0.860
Paclitaxel
  1. Cruz-Collazo AM, Katsara O, Grafals-Ruiz N, Colon Gonzalez J, Dorta-Estremera S, Carlo VP, Chorna N, Schneider RJ, Dharmawardhane S. Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel. Mol Cancer Ther. 2024 Nov 04; 23(11):1613-1625.
    View in: PubMed
    Score: 0.860
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support